Prevention ofClostridium difficileInfection withSaccharomyces boulardii: A Systematic Review | Zendy

Jennifer Tung | Zendy; Lisa Dolovich | Zendy; Christine H. Lee | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prevention ofClostridium difficileInfection withSaccharomyces boulardii: A Systematic Review

Author(s) -

Jennifer Tung,

Lisa Dolovich,

Christine H. Lee

Publication year - 2009

Publication title -

canadian journal of gastroenterology

Language(s) - English

Resource type - Journals

eISSN - 1916-7237

pISSN - 0835-7900

DOI - 10.1155/2009/915847

Subject(s) - saccharomyces boulardii , medicine , clostridium difficile , antibiotic associated diarrhea , diarrhea , randomized controlled trial , adverse effect , enterocolitis , cinahl , antibiotics , intensive care medicine , probiotic , microbiology and biotechnology , genetics , psychiatry , bacteria , psychological intervention , biology

Clostridium difficile is a major cause of antibiotic-associated diarrhea within the hospital setting. The yeast Saccharomyces boulardii has been found to have some effect in reducing the risk of C difficile infection (CDI); however, its role in preventive therapy has yet to be firmly established.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research